Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000633657 | SCV000754912 | pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2024-01-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 85 of the ACADM protein (p.Gly85Cys). This variant is present in population databases (no rsID available, gnomAD 0.002%). This missense change has been observed in individual(s) with medium chain acyl-CoA dehydrogenase deficiency (PMID: 15171998, 20434380; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 497550). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACADM protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000633657 | SCV002023970 | likely pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2020-11-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000633657 | SCV004217256 | pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000593338 | SCV005325430 | likely pathogenic | not provided | 2023-12-23 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 20434380, 15171998, 22683754, 32778825, 16291504) |
Eurofins Ntd Llc |
RCV000593338 | SCV000702140 | uncertain significance | not provided | 2016-10-24 | flagged submission | clinical testing |